ConductScience.org, home

Gene · 2030

SLC29A1: solute carrier family 29 member 1 (Augustine blood group)

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. SLC29A1: solute carrier family 29 member 1 (Augustine blood group). Genes, record 2030. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2030

On this page

Gene

Symbol
SLC29A1
HGNC
Name
solute carrier family 29 member 1 (Augustine blood group)
HGNC
NCBI Gene ID
2030
NCBI Gene
HGNC ID
HGNC:11003
HGNC
Ensembl
ENSG00000112759
NCBI Gene
Aliases
AUG, ENT1, hENT1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q99808Equilibrative nucleoside transporter 14563Ensembl, GeneID, HGNC

Source UniProt

Patents96

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
US 12534732 B22026-01-27922Q99808Espacenet
JP 2026012378 A2026-01-23922Q99808Espacenet
JP 2026004568 A2026-01-1464395Q99808Espacenet
JP 2026004568 A2026-01-1464396Q99808Espacenet
JP 2026004568 A2026-01-1464397Q99808Espacenet
JP 2026004568 A2026-01-1464398Q99808Espacenet
JP 2026004568 A2026-01-1464399Q99808Espacenet
JP 2026004568 A2026-01-1464400Q99808Espacenet
JP 2026004568 A2026-01-1464401Q99808Espacenet
JP 2026004568 A2026-01-1464402Q99808Espacenet

1 to 10 of 96

See all 96 patents

Drugs1

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismAction
DIPYRIDAMOLECHEMBL932Equilibrative nucleoside transporter 1 inhibitorINHIBITOR

Source ChEMBL

Trials20

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT07199504DIPYRIDAMOLEPHASE2/PHASE3ClinicalTrials.gov
NCT05166876DIPYRIDAMOLEPHASE22023-02-06ClinicalTrials.gov
NCT04424901DIPYRIDAMOLEPHASE22023-04-21ClinicalTrials.gov
NCT04410328DIPYRIDAMOLEPHASE32025-02-21ClinicalTrials.gov
NCT03015974DIPYRIDAMOLEClinicalTrials.gov
NCT02966119DIPYRIDAMOLEPHASE3ClinicalTrials.gov
NCT02782260DIPYRIDAMOLEPHASE2ClinicalTrials.gov
NCT02121756DIPYRIDAMOLEPHASE1/PHASE22019-04-11ClinicalTrials.gov
NCT01612377DIPYRIDAMOLEPHASE2ClinicalTrials.gov
NCT01369745DIPYRIDAMOLEPHASE22014-04-30ClinicalTrials.gov

1 to 10 of 20

See all 20 trials

NIH grants1,270

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleSLC29A1 papersNewest fiscal year
P30ES006694Southwest Environmental Health Sciences Center92025
P30CA008748Cancer Center Support Grant82025
T32ES007091Training in Environmental Toxicology of Human Disease82025
ZIADA000493Functional and Pharmacological Significance of Receptor Heteromers in the CNS82025
P30CA016672Cancer Center Support Grant72025
R01CA132946Genomics of AML Prognosis72025
ZIADK031117Development of Drugs Acting at Adenosine Receptors72025
P30CA021765Cancer Center Support Grant (CCSG)52025
P30CA014520UW Comprehensive Cancer Center Support42025
U10CA180886COG NCTN Network Group Operations Center - Year 11 STAR Act MCI and PEC Supplement42025

1 to 10 of 1,270Source NIH's project files

See all 1,270 nih grants

Papers2,306

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Tissue compartment limits the apparent late-stage decline in hepatic ENT1.Metabolism202642790774PubTator, text miningPubMed
Nucleolin shields PTBP1 from autophagic degradation to sustain gemcitabine resistance in bladder cancer.Drug Resist Updat202642790162PubTator, text miningPubMed
Response to "Tissue compartment limits the apparent late-stage decline in hepatic ENT1".Metabolism202642753861PubTator, text miningPubMed
Enhancing gemcitabine uptake by promoting dimerization of ENT1 transporter improves response rates of patients with sarcoma.J Clin Invest202642691249PubTator, text miningPubMed
The Potential of Cannabidiol for the Treatment of Psychosis: Endocannabinoid Regulation of Serotonergic Neurotransmission via Serotonin 5-HT1A/2A Receptors.Neurochem Res202642658346PubTator, text miningPubMed
Anticonvulsant effects, safety, and sex-dependent molecular signatures of cannabidiol treatment in a preclinical model of audiogenic epilepsy.Front Pharmacol202642630256PubTator, text miningPubMed
Construction and validation of a nomogram for the diagnosis of postmenopausal osteoporosis.Mol Med Rep202642596822PubTator, text miningPubMed
ZBED6-driven nucleotide metabolic reprogramming improves sensitivity to anti-PD1 therapy in NK/T cell lymphoma.Drug Resist Updat202642585696PubTator, text miningPubMed
Pan-cancer multi-omics analysis of pharmacogenomic alterations.Front Bioinform202642558488PubTator, text miningPubMed
Repurposed cAMP-Modulating Agents Enhance 5-Fluorouracil Response Through Membrane-Dependent Mechanisms.Membranes (Basel)202642506183PubTator, text miningPubMed

1 to 10 of 2,306

See all 2,306 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/2030

GET https://conductscience.org/api/genes/v1/2030/patents?page=2